Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.
Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients / N. Wulffraat, N. Ruperto, H. Brunner, S. Oliveira, Y. Uziel, K. Nistala, R. Cimaz, M. Ferrandiz, B. Flato, M. Gamir, I. Kone Paut, C. Gaillez, K. Lheritier, K. Abrams, A. Martini, D. Lovell. - In: ARTHRITIS & RHEUMATOLOGY. - ISSN 2326-5191. - 66:suppl. 10(2014), pp. S413-S414.
Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients
R. Cimaz;
2014
Abstract
Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
